Page last updated: 2024-10-28

hydralazine and Infarct

hydralazine has been researched along with Infarct in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammond, TG1
Mosesson, MW1
Omae, T1
Tanaka, K1

Other Studies

2 other studies available for hydralazine and Infarct

ArticleYear
Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.
    Archives of internal medicine, 1989, Volume: 149, Issue:2

    Topics: Adult; Anemia, Sickle Cell; Humans; Hydralazine; Hypertension, Pulmonary; Hypotension; Infarction; I

1989
Release of pressor substances from infarcted kidneys in rats. I. Effect of chronic administration of hydralazine.
    Japanese heart journal, 1971, Volume: 12, Issue:1

    Topics: Administration, Oral; Animals; Blood Pressure; Female; Hydralazine; Infarction; Kidney; Kidney Trans

1971